Rogier A. Oldenburg

5.9k total citations
26 papers, 846 citations indexed

About

Rogier A. Oldenburg is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Rogier A. Oldenburg has authored 26 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Rogier A. Oldenburg's work include BRCA gene mutations in cancer (9 papers), Adrenal and Paraganglionic Tumors (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Rogier A. Oldenburg is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Adrenal and Paraganglionic Tumors (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Rogier A. Oldenburg collaborates with scholars based in Netherlands, United States and Canada. Rogier A. Oldenburg's co-authors include Peter Devilee, Esther Korpershoek, Winand N.M. Dinjens, Cees J. Cornelisse, Ronald R. de Krijger, Marjon A. van Slegtenhorst, Arend F. L. Schinkel, Michelle Michels, Hannah G. van Velzen and Hanne Meijers‐Heijboer and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Rogier A. Oldenburg

23 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rogier A. Oldenburg Netherlands 18 329 297 271 241 173 26 846
Marine Guillaud-Bataille France 15 254 0.8× 365 1.2× 76 0.3× 285 1.2× 166 1.0× 27 781
Romolo Sandrini Brazil 10 477 1.4× 284 1.0× 166 0.6× 536 2.2× 197 1.1× 16 912
Luiz DeLacerda Brazil 8 442 1.3× 281 0.9× 136 0.5× 489 2.0× 169 1.0× 9 819
Richard J. Dahl United States 12 155 0.5× 280 0.9× 146 0.5× 64 0.3× 83 0.5× 16 762
George Zogopoulos Canada 19 275 0.8× 268 0.9× 226 0.8× 232 1.0× 106 0.6× 54 975
Susanne V. Allander Sweden 12 115 0.3× 302 1.0× 99 0.4× 93 0.4× 188 1.1× 18 728
T Pasha United States 11 82 0.2× 234 0.8× 95 0.4× 127 0.5× 216 1.2× 12 678
Adam Stenman Sweden 17 223 0.7× 229 0.8× 159 0.6× 303 1.3× 578 3.3× 51 934
Claudio De Vito Switzerland 15 227 0.7× 358 1.2× 44 0.2× 184 0.8× 108 0.6× 42 824
E. Futo Switzerland 10 212 0.6× 400 1.3× 139 0.5× 70 0.3× 605 3.5× 11 807

Countries citing papers authored by Rogier A. Oldenburg

Since Specialization
Citations

This map shows the geographic impact of Rogier A. Oldenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier A. Oldenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier A. Oldenburg more than expected).

Fields of papers citing papers by Rogier A. Oldenburg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogier A. Oldenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier A. Oldenburg. The network helps show where Rogier A. Oldenburg may publish in the future.

Co-authorship network of co-authors of Rogier A. Oldenburg

This figure shows the co-authorship network connecting the top 25 collaborators of Rogier A. Oldenburg. A scholar is included among the top collaborators of Rogier A. Oldenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier A. Oldenburg. Rogier A. Oldenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ausems, Margreet G.E.M., Inge M. van Oort, C. Marleen Kets, et al.. (2024). Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives. Familial Cancer. 23(2). 165–175.
2.
Zandee, Wouter T., Richard A. Feelders, Johannes Hofland, et al.. (2019). Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE. European Journal of Endocrinology. 181(1). 45–53. 57 indexed citations
3.
Verhagen, Judith M.A., Paul A. van der Zwaag, Jan H. von der Thüsen, et al.. (2018). Lack of evidence for a causal role of CALR3 in monogenic cardiomyopathy. European Journal of Human Genetics. 26(11). 1603–1610. 5 indexed citations
4.
Oldenburg, Rogier A., et al.. (2018). Arthroscopic soft-tissue interposition arthroplasty of the glenohumeral joint for ochronotic arthropathy: A case report. Journal of Orthopaedic Science. 25(4). 734–738.
5.
Velzen, Hannah G. van, Pieter A. Vriesendorp, Rogier A. Oldenburg, et al.. (2016). Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 118(6). 881–887. 32 indexed citations
6.
Korpershoek, Esther, Bert H.J. Eussen, Lindsey Oudijk, et al.. (2015). Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis. The Journal of Clinical Endocrinology & Metabolism. 101(2). 453–460. 39 indexed citations
7.
Korpershoek, Esther, Bart‐Jeroen Petri, Edward P. Post, et al.. (2014). Adrenal Medullary Hyperplasia Is a Precursor Lesion for Pheochromocytoma in MEN2 Syndrome. Neoplasia. 16(10). 868–873. 42 indexed citations
8.
Bayley, Jean‐Pierre, Rogier A. Oldenburg, Attje S. Hoekstra, et al.. (2014). Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations. BMC Medical Genetics. 15(1). 111–111. 33 indexed citations
9.
Adank, Muriel A., Senno Verhoef, Rogier A. Oldenburg, et al.. (2013). Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases. European Journal of Cancer. 49(8). 1993–1999. 13 indexed citations
10.
Harinck, Femme, Irma Kluijt, Nienke van der Stoep, et al.. (2012). Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas. Journal of Medical Genetics. 49(6). 362–365. 29 indexed citations
11.
Oudijk, Lindsey, José Gaal, Esther Korpershoek, et al.. (2012). SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors. Modern Pathology. 26(3). 456–463. 62 indexed citations
12.
Harinck, Femme, Irma Kluijt, Theo A. van Os, et al.. (2011). Indication for CDKN2A Mutation Analysis in Familial Pancreatic Cancer-Families Without Melanomas. Gastroenterology. 140(5). S–194. 1 indexed citations
13.
Ruijs, Mariëlle, Annegien Broeks, Fred H. Menko, et al.. (2009). The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype. Hereditary Cancer in Clinical Practice. 7(1). 4–4. 29 indexed citations
14.
Dooren, Marieke F. van, Aida M. Bertoli‐Avella, & Rogier A. Oldenburg. (2009). Premature ovarian failure and gene polymorphisms. Current Opinion in Obstetrics & Gynecology. 21(4). 313–317. 21 indexed citations
15.
Oldenburg, Rogier A., Jeanine J. Houwing‐Duistermaat, Jean‐Pierre Bayley, et al.. (2008). Genome‐wide linkage scan in Dutch hereditary non‐BRCA1/2 breast cancer families identifies 9q21‐22 as a putative breast cancer susceptibility locus. Genes Chromosomes and Cancer. 47(11). 947–956. 15 indexed citations
16.
González‐Neira, Anna, Juan Manuel Rosa-Rosa, Ana Osório, et al.. (2007). Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies. BMC Genomics. 8(1). 299–299. 19 indexed citations
17.
Oldenburg, Rogier A., Hanne Meijers-Heijboer, Nicoline Hoogerbrugge, et al.. (2006). Characterization of Familial Non-BRCA1/2Breast Tumors by Loss of Heterozygosity and Immunophenotyping. Clinical Cancer Research. 12(6). 1693–1700. 25 indexed citations
18.
Szabo, Csilla I., Mieke Schutte, Annegien Broeks, et al.. (2004). Are ATM Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?. Cancer Research. 64(3). 840–843. 43 indexed citations
19.
Oldenburg, Rogier A., Jaco Kraan, Hans Morreau, et al.. (2003). The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.. PubMed. 63(23). 8153–7. 93 indexed citations
20.
Oldenburg, Rogier A.. (1999). Search for new breast cancer susceptibility genes. Data Archiving and Networked Services (DANS). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marine Guillaud-Bataille Breakdown of academic impact, for papers by Romolo Sandrini Breakdown of academic impact, for papers by Luiz DeLacerda Breakdown of academic impact, for papers by Richard J. Dahl Breakdown of academic impact, for papers by George Zogopoulos Breakdown of academic impact, for papers by Susanne V. Allander Breakdown of academic impact, for papers by T Pasha Breakdown of academic impact, for papers by Adam Stenman Breakdown of academic impact, for papers by Claudio De Vito Breakdown of academic impact, for papers by E. Futo
Rankless by CCL
2026